Authors: Brown, J Reading, SJ Jones, S Fitchett, CJ Howl, J Martin, A Longland, CL Michelangeli, F Dubrova, YE Brown, CA

Citation: J. Brown et al., Critical evaluation of ECV304 as a human endothelial cell model defined bygenetic analysis and functional responses: A comparison with the human bladder cancer derived epithelial cell line t24/83, LAB INV, 80(1), 2000, pp. 37-45

Authors: Howl, J

Citation: J. Howl, Fluorescent and biotinylated probes for B-2 bradykinin receptors: Agonistsand antagonists, PEPTIDES, 20(4), 1999, pp. 515-518

Authors: Hallbrink, M Saar, K Ostenson, CG Soomets, U Efendic, S Howl, J Wheatley, M Zorko, M Langel, U

Citation: M. Hallbrink et al., Effects of vasopressin-mastoparan chimeric peptides on insulin release andG-protein activity, REGUL PEPT, 82(1-3), 1999, pp. 45-51

Authors: Gu, Y Preston, MR El Haj, AJ Hamid, J Zamponi, GW Howl, J Publicover, SJ

Citation: Y. Gu et al., Osteoblasts derived from load-bearing bones of the rat express both L- andT-like voltage-operated calcium channels and mRNA for alpha(1C), alpha(1D)and alpha(1G) subunits, PFLUG ARCH, 438(4), 1999, pp. 553-560

Authors: Howl, J Prochazka, Z Wheatley, M Slaninova, J

Citation: J. Howl et al., Novel strategies for the design of receptor-selective vasopressin analogues: Aib-substitution and retro-inverso transformation, BR J PHARM, 128(3), 1999, pp. 647-652